Methotrexate treatment and risk for cutaneous malignant melanoma: a retrospective comparative registry-based cohort study-Reference-Cited by-同舟云学术

Methotrexate treatment and risk for cutaneous malignant melanoma: a retrospective comparative registry-based cohort study

Published:2017-04-26 Issue:6 Volume:176 Page:1492-1499
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Polesie S.¹,Gillstedt M.¹,Sönnergren H.H.²,Osmancevic A.¹,Paoli J.¹

Affiliation:

1. Department of Dermatology and Venereology; Sahlgrenska University Hospital; Institute of Clinical Sciences at the Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

2. Department of Dermatology and Venereology; Skåne University Hospital; Lund Sweden

Funder

American Liver Foundation

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15170/fullpdf

Reference24 articles.

1. Molecular action of methotrexate in inflammatory diseases;Chan;Arthritis Res,2002

2. Does methotrexate increase the risk of infection or malignancy?;Kanik;Rheum Dis Clin North Am,1997

3. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate;Buchbinder;Arthritis Rheum,2008

4. Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study;Nyfors;Dermatologica,1983

5. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy;Stern;Cancer,1982

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin Cancer in the Immunocompromised Patient;Rook's Textbook of Dermatology;2024-03-19

2. Melanoma Risk with Immunomodulators;Melanoma;2024

3. Risk of Melanoma and Non-Melanoma Skin Cancer in Patients with Psoriasis and Psoriatic Arthritis Treated with Targeted Therapies: A Systematic Review and Meta-Analysis;Pharmaceuticals;2023-12-21

4. Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events;Pharmaceuticals;2023-11-15

5. Skin Cancer Correlations in Psoriatic Patients;Cancers;2023-04-25